Andrea Rubboli

Suggest Changes
Learn More
Despite the clear net clinical benefit of oral anticoagulation (OAC) in atrial fibrillation (AF) patients at risk for stroke, major bleeding events (especially intra-cranial bleeds) may be(More)
Management of antithrombotic therapy in atrial fibrillation patientspresentingwith acutecoronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of(More)
BACKGROUND Recent reports have provided evidence that bridging therapy with low-molecular-weight heparin (LMWH) may increase bleeding complications in patients with atrial fibrillation (AF) on oral(More)
OBJECTIVE To compare the efficacy and safety of dual antiplatelet therapy (DAPT) and triple therapy (TT, dual antiplatelet plus warfarin) in patients with myocardial infarction (MI) or PCI with(More)